Clinical trialNCT03040141CompletedPhase 2Interventional

Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A

SponsorVisterra, Inc.Enrollment89Influenza A

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Oldach, MD
Visterra, Inc.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

114 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Visterra
Adelaide, South Australia, Australia
Visterra
Melbourne, Australia
Visterra
Parkville, Australia
Visterra
South Brisbane, Australia
Visterra
Westmead, Australia
Visterra
Woolloongabba, Australia

Belarus

Visterra
Brest, Belarus
Visterra
Grodno, Belarus
Visterra
Grodno, Belarus
Visterra
Homyel, Belarus
Visterra
Homyel, Belarus
Visterra
Lesnoy, Belarus
Visterra
Minsk, Belarus
Visterra
Vitebsk, Belarus

Belgium

Visterra
Brussels, Belgium
Visterra
Edegem, Belgium

Bulgaria

Visterra
Kozloduy, Bulgaria
Visterra
Montana, Bulgaria
Visterra
Plovdiv, Bulgaria
Visterra
Sofia, Bulgaria
Visterra
Sofia, Bulgaria
Visterra
Sofia, Bulgaria
Visterra
Veliko Tarnovo, Bulgaria

Canada

Visterra
Moncton, New Brunswick, Canada

Estonia

Visterra
Pärnu, Estonia
Visterra
Tallinn, Estonia
Visterra
Tallinn, Estonia
Visterra
Tallinn, Estonia
Visterra
Tartu, Estonia

France

Visterra
La Roche-sur-Yon, France
Visterra
La Tronche, France
Visterra
Limoges, France
Visterra
Metz-Tessy, France
Visterra
Nantes, France
Visterra
Paris, France
Visterra
Paris, France
Visterra
Quimper, France

Georgia

Visterra
Tbilisi, Georgia
Visterra
Tbilisi, Georgia
Visterra
Tbilisi, Georgia

74 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 3 Jan 2018
Primary completion: 22 Nov 2018
Completion: 22 Nov 2018
Last update posted: 28 Dec 2022
Registered enrollment: 89
Registry id: NCT03040141

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.